- Open Access
Physiological characterization of secondary metabolite producing Penicillium cell factories
© The Author(s) 2017
- Received: 22 August 2017
- Accepted: 26 September 2017
- Published: 17 October 2017
Penicillium species are important producers of bioactive secondary metabolites. However, the immense diversity of the fungal kingdom is only scarcely represented in industrial bioprocesses and the upscaling of compound production remains a costly and labor intensive challenge. In order to facilitate the development of novel secondary metabolite producing processes, two routes are typically explored: optimization of the native producer or transferring the enzymatic pathway into a heterologous host. Recent genome sequencing of ten Penicillium species showed the vast amount of secondary metabolite gene clusters present in their genomes, and makes them accessible for rational strain improvement. In this study, we aimed to characterize the potential of these ten Penicillium species as native producing cell factories by testing their growth performance and secondary metabolite production in submerged cultivations.
Cultivation of the fungal species in controlled submerged bioreactors showed that the ten wild type Penicillium species had promising, highly reproducible growth characteristics in two different media. Analysis of the secondary metabolite production using liquid chromatography coupled with high resolution mass spectrometry proved that the species produced a broad range of secondary metabolites, at different stages of the fermentations. Metabolite profiling for identification of the known compounds resulted in identification of 34 metabolites; which included several with bioactive properties such as antibacterial, antifungal and anti-cancer activities. Additionally, several novel species–metabolite relationships were found.
This study demonstrates that the fermentation characteristics and the highly reproducible performance in bioreactors of ten recently genome sequenced Penicillium species should be considered as very encouraging for the application of native hosts for production via submerged fermentation. The results are particularly promising for the potential development of the ten analysed Penicillium species for production of novel bioactive compounds via submerged fermentations.
- Submerged fermentation
- Secondary metabolite
- Cell factory
Filamentous fungi are important producers of secondary metabolites: low-molecular-weight compounds that often have bioactive properties. The genus Penicillium currently includes more than 354 accepted species  many of which are capable of producing a wide variety of secondary metabolites . The most well-known secondary metabolite produced by Penicillium is the antibiotic penicillin, which was discovered by Fleming  and which is nowadays produced in large scale using P. rubens, following intense strain improvement programs aimed at increasing the titers. Other important pharmaceutical compounds produced by Penicillium species include the antifungal griseofulvin , the immunosuppressant mycophenolic acid  and the cholesterol lowering drug compactin/mevastatin [6–8]. These examples illustrate the great importance of Penicillium species as production hosts and sources of bioactive compounds with medical applications. On the other hand, Penicillium species can also produce mycotoxins such as citrinin, ochratoxin and patulin , which can pose a health risk to humans and animals.
The increasing prevalence of antibiotic resistance among pathogenic bacteria was in 2016 named by the UN General Assembly to be amongst the greatest and most urgent global risk factor for the health of humans . However, the discovery of novel antibiotics has stagnated since the 1970’s and only few novel classes of antibiotics have been discovered since then [10, 11]. This is most likely a consequence of the fact that drug development is time consuming and expensive, while market value and dominance for antibiotics is limited by the development of resistance. The broad metabolic diversity found within the fungal kingdom, however, continues to provide a rich source of novel drug leads, this coupled with advancements within process engineering and physiological characterization tools, provides a strong basis for exploiting the chemical and physiological diversity in fungi to establish novel fungal based bioprocesses which can meet the demands of modern society for novel antimicrobials and pharmaceuticals.
To facilitate the process from identification of a beneficial compound to the establishment of an industrially feasible bio-based production process, two major strategies can be followed; i.e. find and optimizing the best native producer or transfer the involved genes to an established heterologous host. The latter strategy is typically desirable if the native producer is not suitable for industrial fermentation processes or is genetically inaccessible. However, production of secondary metabolites in heterologous hosts is still in the developmental stage and expressing complex multistep pathways to commercially viable titers has proven highly challenging and typically requires substantial optimization . The transfer of the given genetic trait in addition requires a thorough understanding of the given biosynthetic pathway and the involved genes. The other strategy, advancement of the native organism for the production of secondary metabolites, can be favourable as this eliminates the often tedious work of moving the biosynthetic pathway to a heterologous host. However, taming a uncharacterized filamentous fungus for industrial scale production is not trivial, as natural secondary metabolite yields are often low which combined with the complex interplay between physiology, physical environment and morphology often causes problems during fermentation such as nonhomogeneous mixing and nutrient limitation . Therefore, in many instances, relatively unexploited fungi are not tested in submerged bioreactor cultivations, even though this would provide the necessary process performance data to evaluate whether to optimize the native producing organism or to transfer the pathway into a heterologous host.
The recent genome sequencing of ten Penicillium species [14, 15] has provided valuable novel insight into the rich diversity in secondary metabolite gene clusters present in these Penicillium species and has in addition, made the species amenable to rational strain improvement. In this study, we analyzed the potential of these ten recently genome sequenced Penicillium species as native producing cell factories. The species were cultivated in highly controlled bioreactors both in a defined medium that allowed for quantitative physiological evaluation and in a secondary metabolite inducing complex medium, to evaluate overall process performance, growth rates and reproducibility. Additionally, secondary metabolite profiles of the species during different time points in the fermentation were studied. To our knowledge, none of these species had been tested in a bioreactor before. This work demonstrates an implementation strategy for novel fungal cell factories based on highly controlled submerged bioreactors cultivations and quantification of key physiological parameters.
The species used in this study were P. coprophilum (IBT31321), P. nalgiovense (IBT 13039), P. polonicum (IBT 4502), P. antarcticum (IBT31811), P. vulpinum (IBT 29486), P. arizonense (IBT 12289), P. solitum (IBT 29525), P. decumbens (IBT11843), P. flavigenum (IBT 14082), and P. steckii (IBT 24891). All strains are available from the IBT culture collection (Department of Biotechnology and Biomedicine, Technical University of Denmark).
Submerged bioreactor batch cultivations
With the aim of investigating the growth characteristics of ten potential secondary metabolite producing Penicillium species, submerged bioreactor cultivations were performed with each species in two different media in biological triplicates.
Czapek yeast autolysate (CYA) medium was used for spore propagation, containing per liter of demineralized water: 30 g sucrose, 5 g yeast extract, 3 g NaNO3, 1 g K2HPO4, 0.5 g MgSO4·7H2O, 0.5 g KCl, 0.01 g FeSO4·7H2O, 20 g agar and 1 mL trace metal solution containing 0.1 g/L ZnSO4·7H2O and 0.05 g/L CuSO4·5H2O. The pH was adjusted to 6.2 with NaOH prior to autoclaving. All chemicals applied were obtained from Sigma-Aldrich (Sigma-Aldrich).
Batch cultivations were performed in CY medium (CM) and in a defined medium (DM) for Penicillium. The defined medium contained per liter of demineralized water: 15 g glucose, 3.5 g (NH4)2SO4, 0.5 g MgSO4·7H2O, 0.15 g Na2-EDTA, 0.04 g FeSO4·7H2O, 0.8 g KH2PO4, 5 mL trace solution containing 1 g/L CuSO4·5H2O, 4 g/L ZnSO4·7H2O, 4 g/L MnSO4·7H2O, 1 g/L CaCl2·H2O. The CY medium contained the same components as stated above for spore propagation without the agar and 15 g sucrose per liter. The medium was heat sterilized by autoclaving at 121 °C for 20 min. After media sterilization, a sucrose solution (for CM) or glucose solution (for DM), separately autoclaved at 121 °C, was added.
Preparation of spore inoculum
Spores were propagated on CYA plates for 7 days and harvested with approximately 5 mL of cold MiliQ water containing 0.9% NaCl and 0.01% Tween solution, followed by filtration through Miracloth (Merck Millipore), centrifuged at 5000 g and the spore pellet washed again with 10 mL MiliQ water. Spores were counted using a Bürker–Türk counting chamber, followed by inoculation of bioreactors to a final spore concentration of 1 × 109 spores/L.
All bioreactor batch cultivations were carried out in Sartorious 1 L bioreactors (Satorious Stedim Biotech) with a working volume of 0.9 L, equipped with 2 Rushton six-blade disc turbines. Throughout the cultivation the temperature was maintained at 25 °C and the pH was kept constant at 6.5 by automatic addition of 2 M NaOH or H2SO4. The bioreactors were sparged with sterile atmospheric air. For the first 1200 min, the airflow was linearly increased from 0.1 volume of air per volume of liquid per minute (vvm) to 0.9 vvm and the stirring rate from 100 to 600 rpm. After that, these parameters were kept constant. The off-gas concentrations of oxygen and carbon dioxide were measured with a Prima Pro Process Mass Spectrometer (Thermo-Fischer Scientific), calibrated monthly with gas mixtures containing 5% (v/v) CO2, 0.04% (v/v) ethanol and methanol, 1% (v/v) argon, 5% (v/v) and 15% (v/v) oxygen all with nitrogen as carrier gas. The pH electrode (Mettler Toledo) was calibrated according to manufacturer’s standard procedures.
Biomass dry weight determination
Growth rates were determined based on biomass dry weight samples collected during the exponential growth phase. First a known amount of cell culture (typically around 3 mL) was filtered through pre-dried and weighted 0.45 µm polyether sulfone filters (Sartorius Stedim Biotech) which was then washed with demineralized water. The filter was folded to lock the biomass inside and dried in a microwave at 150 W for 20 min. The dry weight was measured after a cooling period of approximately 30 min in a desiccator.
Glucose concentration determination
For quantification of the glucose concentration in the culture medium, fermentation broth was filtered through a Q-Max® Ca-Plus Filter (Frisenette ApS) with a pore size of 0.45 µm and stored at −20 °C until analysis. Separation and detection of the compounds was accomplished with a high performance liquid chromatography (HPLC) system equipped with a Bio-Rad Aminex HPX-87H column (BioRad) coupled to a RI detector. Elution was performed isocratically with H2SO4 (5 mM) as the mobile phase with a flow velocity of 0.6 mL/min at 60 °C. Quantification was performed using a six-level external calibration curve.
Calculations of physiological characteristics
The end of the lag phase was determined as the time point were the percentage of CO2 in the off gas was consecutively over 6%.
Maximum specific growth rates were calculated via linear regression on a semi-logarithmic scale on at least three experimental biomass dry weight data points during the exponential phase and all R2 values were at least 0.96. Maximum CO2 production rates where determined similarly but with an R2 of at least 0.99. A custom script was developed in the statistical programming language R to determine the duration of the non-exponential growth phase for all cultivations, defined as the time difference between the end of the exponential fit to the CO2 exhaust, and the time point where the maximum overall CO2 production was reached. The code is available at: https://github.com/JensChrNielsen/Fungal-Biol-Biotechnol-2017.
The overall biomass yield on glucose was calculated as the ratio between the biomass gain and the glucose consumption in the growth phase.
Secondary metabolite analysis
With the aim of identifying the secondary metabolite profiles in the fermentation broth of the ten Penicillium species grown in two different media, the filtered broth was extracted with ethyl acetate, analyzed with ultra-high performance liquid chromatography-diode array detection-quadrupole time of flight mass spectrometry UHPLC–DAD–QTOFMS, and known compounds were identified using an in-house compound library.
The fermentation broth was filtered through a 0.45 µm cellulose acetate filter (Frisenette), for extraction of non-polar compounds 1.0 mL of ethyl acetate extraction solvent was added to 0.8 mL of filtrate. After ultra-sonification for 1 h and centrifugation for 1 min at 13,000g the organic (top) layer was transferred to a clean vial. For extraction of polar compounds 1.0 mL of acidic ethyl acetate (ethyl acetate + 0.5% formic acid) was added to the remaining filtrate. Following ultra-sonification and centrifugation the organic (top) layer was added to the extraction solution containing the extracted non-polar compounds. The combined solution was evaporated to dryness and re-dissolved in 125 µL HPLC grade methanol. After centrifugation for 5 min at 13,000g the supernatant was directly used for chemical analysis.
Secondary metabolite analysis was achieved by UHPLC–DAD–QTOFMS on a maXis HD orthogonal acceleration quadrupole time-of-flight mass spectrometer (Bruker Daltonics) equipped with an electrospray ionization (ESI) source and coupled to an Ultimate 3000 UHPLC system (Dionex, Thermo Scientific). Separation was achieved with a Kinetex 2.6 µm C18, 100 × 2.1 mm (Phenomenex) column maintained at 40 °C with a flow rate of 0.4 mL/min. A linear gradient system composed of 20 mmol/L formic acid in water, and 20 mmol/L formic acid in acetonitrile was used, starting from 10% (v/v) acetonitrile and increased to 100% in 10 min, maintaining this rate for 3 min before returning to the starting conditions. The system was re-equilibrated before subsequent sample analysis. MS analysis was performed in ESI+ with a data acquisition rate of 10 scans per second at m/z 100–1000, switching between 0 and 20 eV fragmentation energy.
Identification of secondary metabolites
Identification of secondary metabolites was performed using aggressive dereplication of the full scan high resolution (HR) MS data, and pseudo MS/MS data from the 20 eV fragmentation trace, using a search list of compounds based on former taxonomic identification and a manual search of major peaks in the internal library. This library consists of 1500 compounds of which 95% are fungal secondary metabolites . Compounds were confirmed by comparison of HRMS, UV/Vis and MS/HRMS to a reference standard. The number of peaks was counted by making a list of compounds (dereplicated and unknown ones) based on molecular features in the latest time sample in the fermentation, with an absolute area higher than 500,000 counts and intensity higher than 10,000 counts. Subsequently, the presence of these compounds was searched for in all the other samples. The total amount was determined by counting all compounds that were present in two or three of the triplicate samples, without using a threshold value.
Physiological characteristics of ten Penicillium species cultivated in 1 L bioreactors in DM and CM
Biomass yield growth phase (Ysx)
DM (g DW/g glucose)
0.58 ± 0.05
14.3 ± 0.5
10.9 ± 0.3
0.60 ± 0.17
22.5 ± 0.8
14.5 ± 0.1
0.37 ± 0.03
23.3 ± 0.6
12.2 ± 0.6
0.55 ± 0.02
17.8 ± 0.9
13.8 ± 0.2
0.54 ± 0.14
37.6 ± 1.4
Pellet + clumps + wall
18.3 ± 0.2
0.25 ± 0.01
30.3 ± 1.7
11.3 ± 0.1
0.58 ± 0.03
19.7 ± 0.2
12.5 ± 0.1
0.37 ± 0.02
10.9 ± 2.3
Pellet + wall growth
13.5 ± 0.2
0.29 ± 0.13
19.9 ± 1.2
Pellet + wall growth
9.9 ± 0.2
0.67 ± 0.04
21.4 ± 0.4
14.0 ± 0.8
Secondary metabolite analysis
Additionally, metabolite profiling was performed to identify the known compounds produced during the fermentations. In total 34 different metabolites were identified, from which most of them could be confirmed by comparison of HRMS, UV/Vis and MS/HRMS to a reference standard. Most compounds were unique to one of the ten species, with the exception of chrysogine identified in three species (P. nalgiovense, P. flavigenum and P. antarcticum), fungisporin in three species (P. coprophilum, P. nalgiovense and P. flavigenum) and andrastin A in two species (P. vulpinum and P. decumbens), while andrastin C was only identified in P. decumbens. Additionally, the roquefortine pathway was identified in three species (P. coprophilum, P. vulpinum and P. flavigenum), where depending on the media and species, different intermediates and end products of this pathway could be identified; in P. flavigenum only meleagrin and precursors were identified while both in P. coprophilum and P. vulpinum the end product of the pathway, oxaline was identified. Three species–metabolite relationships have, to our knowledge, not been described in literature before: P. vulpinum and P. decumbens producing andrastin A and P. flavigenum producing chrysogine.
To identify in which stages of the fermentation the various metabolites were produced, we examined the individual metabolite production profiles covering the three analyzed stages of the fermentation, one during the growth phase, one a few hours after the CO2 values started decreasing and one in the stationary phase (depicted as triangles in Fig. 1 and exact values in Additional file 2). This analysis revealed production of specific metabolites was associated with specific growth phases of the cultivations. For example for P. coprophilum in DM, the metabolites from the roquefortine/oxaline pathway were already present in the first sample, while griseofulvin and dechlorogriseofulvin could only be detected in the last sample. Another example of this stage depending production was P. steckii grown in CM where the vast majority of the metabolites were identified at the second sample point, while trichodermamide C was only first observed at the third sample point. Many of the metabolites in P. steckii were identified as belonging to the family of hynapenes and arohynapenes (based on UV and accurate mass) but because of a lack of reference standards could not be assigned to specific peaks and are therefore not shown in Table 2. In some cases, metabolites were produced only in CM or DM; penicillic acid was only produced in P. polonicum in CM, calbistrin A was only detected in P. decumbens in CM, and atlantinone A was only detected in P. solitum in DM. This was also seen for unidentified metabolites (Additional file 2). In 17 out of the 20 cultivations the metabolite levels in the third sample were higher than in the second sample, showing that part of the metabolites started to be produced only after the growth phase.
The fungal kingdom contains a huge reservoir of bioactive secondary metabolites; however, the development from discovery of a relevant metabolite to application remains a challenge. The recent genome sequencing of ten secondary metabolite rich Penicillium species facilitates exploitation of their genome sequences and/or their use as native producing cell factories. The aim of this study was to determine the suitability of these ten Penicillia as novel cell factories for native compounds by testing their growth performance and secondary metabolite production in submerged cultivations.
Cultivation of the fungal species in controlled submerged bioreactors proved that the ten wild type Penicillium species all could be cultivated using the same conditions. The cultivations proved to be highly reproducible, both in defined medium (DM) and rich medium (CM). In 18 out of the 20 cultivations, replicate values for CO2 off gas and biomass dry weight concentrations were reproducible with maximum CO2 production rates having standard deviations between 1 and 27%. The cultivations performed in CM showed dispersed growth until the maximum CO2 off gas was reached, while five out of the ten species cultivated in DM showed clump/pelleted growth. The fungal morphology can have an enormous impact on the production of enzymes and primary or secondary metabolites . For example, micro-colonies are required for the production of citric acid by A. niger . However, there is not a defined formula on how morphology affects productivity and it should be tested and optimized for the relevant species and metabolites. The work conducted in this study can be used as a starting point in optimization of process parameters for the production of a specific secondary metabolite.
Maximum specific growth rates in DM were calculated to be between 0.14 and 0.22 h−1 depending on the species, and in CM between 0.17 and 0.29 h−1. In case of pellet formation the cultures grew only exponentially in the beginning of the cultivation prior to pellet formation. The obtained growth rates are reasonable starting points for industrial fermentations, for example the penicillin producing P. chrysogenum, has a maximum growth rate under comparable conditions of around 0.2 h−1 [20, 21]. An interesting observation is that the species with the highest growth rates, P. decumbens and P. coprophilum, have the smallest genome size . The biomass yields during the growth phase on glucose varied highly between species and there was a correlation between yields and morphology: species with low yields all showed pellet formation and/or wall growth, while species with high yields showed dispersed growth. In case of wall growth, this can be explained by the biomass determination method used in this study: broth was sampled from a port in the reactor, which in the case of wall growth resulted in a lower biomass value than the real biomass value in the reactor, and a lower yield. One hypothesis for the low yields observed in pelleted growth cultures is that dense hyphal packing may often result in diffusional limitation of both nutrients and oxygen, which can cause autolysis of the pellet core . This can lead to a decrease of dry cell mass, as was previously observed in cultures of P. chrysogenum where hyphal elements showed cell wall degradation and clear signs of autolysis, even during the culture growth phase .
Similar to the growth profiles, the UHPLC–QTOFMS metabolite profiles showed to be reproducible in the biological triplicates of the batch fermentations. The base peak chromatograms revealed that all ten species produced secondary metabolites in submerged cultivations, with most of the metabolites being unique to one of the ten species. The media composition had an influence on secondary metabolite profiles, with eight out of ten species producing a higher number of compounds in CM than in DM. This is not surprising as the yeast extract containing CYA medium is regarded as a secondary metabolite inducing medium . Some species such as P. solitum and P. flavigenum produced very few metabolites in both media; these species could be interesting for the development of secondary metabolite free production hosts, especially P. flavigenum since it showed to have a high reproducibility and a high growth rate. It has been shown in both P. chrysogenum  and in Streptomyces species [26, 27] that removal of highly producing secondary metabolite pathways can increase the production of other native, or heterologous secondary metabolites. However, the species producing very few secondary metabolites still contain many secondary metabolite biosynthetic gene clusters (BGCs). In a recent large scale genomic analysis of Penicillium genomes, it was found that 24 Penicillium genomes (including the ten used in this study) contained in total 1317 putative BGCs, corresponding to an average of 55 clusters per species . This means that a great number of BGCs were inactive in the conditions used in this study, especially when taken into account that one BGC is often responsible for the biosynthesis of a whole family of related metabolites.
Dereplication of the extracts showed that the species produced a broad spectrum of secondary metabolites belonging to several different metabolite classes (polyketides, non-ribosomal peptides and terpenes). In total we identified 34 different known compounds, of which many for the first time in submerged fermentations. Here, it has to be taken into account that because of the chemical diversity of the secondary metabolites the extraction could not be optimal for all compounds, and it was only possible to obtain semi-quantitative data. Several of the identified compounds are known to have antibacterial, antifungal and anti-cancer activities, such as the antifungal griseofulvin, the antibiotic roquefortines  as well as the promising anti-cancer metabolites andrastin A [29, 30] and calbistrin A . At the same time also several mycotoxins such as patulin and penicillic acid were produced of which elimination need to be considered in a production process. Additionally, we described three new species–metabolite relationships: to our knowledge, this is the first time that P. decumbens and P. vulpinum are described as andrastin A producers and P. flavigenum as chrysogine producer. Furthermore, it was shown that the species produce many unknown compounds at levels above the used detection area threshold; these could be interesting targets for isolation, bioactivity testing and structural elucidation, especially because it is less laborious to isolate metabolites from submerged cultures than from agar plates.
In order to utilize metabolic reprogramming techniques to optimize production of a secondary metabolite, the corresponding BGC of the metabolite must first be identified. The BGCs responsible for production of the detected andrastin A, patulin, griseofulvin, pseurotin A, fungisporin and roquefortine/meleagrin pathways have all previously been identified and characterized [32–42]. Although the experimental characterization was done in different species, represents for each of the listed BGCs, except for andrastin A, were recently identified in at least one of the ten analyzed species used in this study . Several other metabolites with predicted BGCs and previously detected in solid cultivations of the corresponding strains, could not be detected in the submerged cultivations of the same strain. This was the case for yanuthones previously detected in extracts of P. flavigenum grown on agar plates , and fumagillin, pyripyropenes, austalides, and tryptoquivalines, previously detected in extracts of P. arizonense grown on agar plates . In this context it is interesting that a species like P. arizonense only secreted pseurotin A, despite the large potential for producing a vast number of secondary metabolites. This would be an advantage if pseurotin A has to be produced in an industrial fermentation, but a disadvantage if any of its other secondary metabolites should be produced . Furthermore we detected small amounts of penicillin G in the CM extracts of the known penicillin G producer P. nalgiovense, but the intensity and area were lower than the threshold values used in this study. It should be considered that in the experiments conducted in this study the biomass was filtered out and only the secreted metabolites were studied, while in plate experiments the intracellular metabolites are also taken into account.
The results of this study show that the fermentation properties of the ten analysed Penicillium species and the highly reproducible performance in bioreactors should be considered as very encouraging for the application of native hosts for production via submerged fermentation. The Penicillium species (isolates) showed promising growth characteristics for use in large-scale industrial bioprocesses and produced a diverse range of interesting secondary metabolites. The production of specific secondary metabolites can subsequently be optimized by process optimization, classical strain development and/or with metabolic engineering approaches. Furthermore, all ten species used in this study were recently genome sequenced, which makes the use of rational approaches for improving the product yields or eliminating the production of other compounds more accessible thanks to the ongoing development of CRISPR/Cas9 genome editing techniques, which has recently been successfully demonstrated in filamentous fungi [43, 44]. The work conducted in this study can assist in deciding the optimization strategy for specific secondary metabolites produced by one of the ten Penicillium species.
MW, KFN, and JN conceived the study. SG and JCN performed the cultivations and data analysis on physiological parameters. SG performed the chemical extractions and analysis of metabolites. SG, KFN, JCF and TOL evaluated the data on secondary metabolites. SG and JCN wrote the manuscript. MW and RF supervised the work and co-wrote the manuscript. All authors read and approved the final manuscript.
The authors acknowledge Tina Johansen, Martin Nielsen and Milica Randelovic for assistance with fermentations; and Christopher Phippen and Aaron John Christian Andersen for assistance with analytics.
The authors declare that they have no competing interests.
Availability of data and materials
Consent for publication
Ethics approval and consent to participate
This work was supported by the European Commission Marie Curie Initial Training Network Quantfung (FP7-People-2013-ITN, Grant 607332).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Visagie CM, Houbraken J, Frisvad JC, Hong S-B, Klaassen CHW, Perrone G, et al. Identification and nomenclature of the genus Penicillium. Stud Mycol. 2014;78:343–71.View ArticlePubMedPubMed CentralGoogle Scholar
- Frisvad JC, Smedsgaard J, Larsen TO, Samson RA. Mycotoxins, drugs and other extrolites produced by species in Penicillium subgenus Penicillium. Stud Mycol. 2004;49:201–41.Google Scholar
- Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Bull World Health Organ. 1929;79:780–90.Google Scholar
- Oxford AE, Raistrick H, Simonart P. Studies in the biochemistry of micro-organisms: griseofulvin, C(17)H(17)O(6)Cl, a metabolic product of Penicillium griseofulvum Dierckx. Biochem J. 1939;33:240–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Gosio B. Sperimentate su culture pure di bacilli del carbonchio demonstrarano notevole potere antisettica. GR Accad Med Torino. 1893;61:484.Google Scholar
- Brown BAG, Srnale TC, Pharmaceuticals B, Park B, King TJ, Hasenkamp R, et al. Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. J Chem Soc Perkin. 1976;1:1165–8.View ArticleGoogle Scholar
- Frisvad JC, Filtenborg O. Terverticillate penicillia: chemotaxonomy and mycotoxin production. Mycologia. 1989;81:837–61.View ArticleGoogle Scholar
- Florey HW, Jennings MA, Gilliver K, Sanders AG. Mycophenolic acid—an antibiotic from Penicillium brevicompactum Dierckx. Lancet. 1946;247:46–9.View ArticleGoogle Scholar
- United Nations [Internet]. [Cited 2017 July 9]. http://www.un.org/pga/71/2016/09/21/press-release-hl-meeting-on-antimicrobial-resistance/.
- Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol. 2010;1:1–7.View ArticleGoogle Scholar
- Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015;517:455–9.View ArticlePubMedGoogle Scholar
- O’Connor SE. Engineering of secondary metabolism. Annu Rev Genet. 2015;49:1–24View ArticleGoogle Scholar
- Gibbs PA, Seviour RJ, Schmid F. Growth of filamentous fungi in submerged culture: problems and possible solutions. Crit Rev Biotechnol. 2000;20:17–48.View ArticlePubMedGoogle Scholar
- Grijseels S, Nielsen JC, Randelovic M, Nielsen J, Nielsen KF, Workman M, et al. Penicillium arizonense, a new, genome sequenced fungal species, reveals a high chemical diversity in secreted metabolites. Sci Rep. 2016;6:35112.View ArticlePubMedPubMed CentralGoogle Scholar
- Nielsen JC, Grijseels S, Prigent S, Ji B, Dainat J, Nielsen KF, et al. Global analysis of biosynthetic gene clusters reveals vast potential of secondary metabolite production in Penicillium species. Nat Microbiol. 2017;2:17044.View ArticlePubMedGoogle Scholar
- Kildgaard S, Mansson M, Dosen I, Klitgaard A, Frisvad JC, Larsen TO, et al. Accurate dereplication of bioactive secondary metabolites from marine-derived fungi by UHPLC–DAD–QTOFMS and a MS/HRMS library. Mar Drugs. 2014;12:3681–705.View ArticlePubMedPubMed CentralGoogle Scholar
- Boyle DT. A rapid method for measuring specific growth rate of microorganisms. Biotechnol Bioeng. 1977;19:297–300.View ArticlePubMedGoogle Scholar
- Krijgsheld P, Bleichrodt R, van Veluw GJ, Wang F, Müller WH, Dijksterhuis J, et al. Development in Aspergillus. Stud Mycol. 2013;74:1–29.View ArticlePubMedGoogle Scholar
- Gomez R, Schnabel I, Garrido J. Pellet growth and citric acid yield of Aspergillus niger 110. Enzyme Microb Technol. 1988;10:188–91.View ArticleGoogle Scholar
- Nielsen J, Johansen CL, Jacobsen M, Krabben P, Villadsen J. Pellet formation and fragmentation in submerged cultures of Penicillium chrysogenum and its relation to penicillin production. Biotechnol Prog. 1995;11:93–8.View ArticlePubMedGoogle Scholar
- Robin J, Jakobsen M, Beyer M, Noorman H, Nielsen J. Physiological characterisation of Penicillium chrysogenum strains expressing the expandase gene from Streptomyces clavuligerus during batch cultivations. Growth and adipoyl-7-aminodeacetoxycephalosporanic acid production. Appl Microbiol Biotechnol. 2001;57:357–62.View ArticlePubMedGoogle Scholar
- Prosser JI, Tough AJ. Growth mechanisms and growth kinetics of filamentous microorganisms. Crit Rev Biotechnol. 1991;10:253–74.View ArticlePubMedGoogle Scholar
- McNeil B, Berry DR, Harvey LM, Grant A, White S. Measurement of autolysis in submerged batch cultures of Penicillium chrysogenum. Biotechnol Bioeng. 1998;57:297–305.View ArticlePubMedGoogle Scholar
- Frisvad JC. Media and growth conditions for induction of secondary metabolite production. Fungal Second Metab Methods Protoc Methods Mol Biol. 2012;944:47–58.Google Scholar
- Salo OV, Ries M, Medema MH, Lankhorst PP, Vreeken RJ, Bovenberg RAL, et al. Genomic mutational analysis of the impact of the classical strain improvement program on β-lactam producing Penicillium chrysogenum. BMC Genom. 2015;16:937.View ArticleGoogle Scholar
- Komatsu M, Uchiyama T, Omura S, Cane DE, Ikeda H. Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism. Proc Natl Acad Sci. 2010;107:2646–51.View ArticlePubMedPubMed CentralGoogle Scholar
- Gomez-Escribano JP, Bibb MJ. Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb Biotechnol. 2011;4:207–15.View ArticlePubMedPubMed CentralGoogle Scholar
- Kopp-Holtwiesche B, Rehm HJ. Antimicrobial action of roquefortine. Eur J Appl Microbiol Biotechnol. 1979;6:397–401.View ArticleGoogle Scholar
- Rho MC, Toyoshima M, Hayashi M, Uchida R, Shiomi K, Komiyama K, et al. Enhancement of drug accumulation by andrastin A produced by Penicillium sp. FO-3929 in vincristine-resistant KB cells. J Antibiot. 1998;51:68–72.View ArticlePubMedGoogle Scholar
- Shiomi K, Uchida R, Inokoshi J, Tanaka H, Iwai Y, Omura S. Andrastins A-C, new protein farnesyltransferase inhibitors, produced by Penicillium sp. FO-3929. Tetrahedron Lett. 1996;37:1265–8.View ArticleGoogle Scholar
- Bladt TT, Durr C, Knudsen PB, Kildgaard S, Frisvad JC, Gotfredsen CH, et al. Bio-activity and dereplication-based discovery of ophiobolins and other fungal secondary metabolites targeting leukemia cells. Molecules. 2013;18:14629–50.View ArticlePubMedGoogle Scholar
- Matsuda Y, Awakawa T, Abe I. Reconstituted biosynthesis of fungal meroterpenoid andrastin A. Tetrahedron. 2013;69:8199–204.View ArticleGoogle Scholar
- Rojas-Aedo JF, Gil-Durán C, Del-Cid A, Valdés N, Pamela Á, Vaca I, et al. The biosynthetic gene cluster for andrastin A in Penicillium roqueforti. Front Microbiol. 2017;8:1–11.View ArticleGoogle Scholar
- Tannous J, El Khoury R, Snini SP, Lippi Y, El Khoury A, Atoui A, et al. Sequencing, physical organization and kinetic expression of the patulin biosynthetic gene cluster from Penicillium expansum. Int J Food Microbiol. 2014;189:51–60.View ArticlePubMedGoogle Scholar
- Chooi YH, Cacho R, Tang Y. Identification of the viridicatumtoxin and griseofulvin gene clusters from Penicillium aethiopicum. Chem Biol. 2010;17:483–94.View ArticlePubMedPubMed CentralGoogle Scholar
- Maiya S, Grundmann A, Li X, Li SM, Turner G. Identification of a hybrid PKS/NRPS required for pseurotin A biosynthesis in the human pathogen Aspergillus fumigatus. ChemBioChem. 2007;8:1736–43.View ArticlePubMedGoogle Scholar
- Wiemann P, Guo C-J, Palmer JM, Sekonyela R, Wang CCC, Keller NP. Prototype of an intertwined secondary-metabolite supercluster. Proc Natl Acad Sci USA. 2013;110:17065–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Tsunematsu Y, Fukutomi M, Saruwatari T, Noguchi H, Hotta K, Tang Y, et al. Elucidation of pseurotin biosynthetic pathway points to trans-acting C-methyltransferase: generation of chemical diversity. Angew Chem Int Ed. 2014;53:8475–9.View ArticleGoogle Scholar
- Ali H, Ries MI, Lankhorst PP, Van Der Hoeven RAM, Schouten OL, Noga M, et al. A non-canonical NRPS is involved in the synthesis of fungisporin and related hydrophobic cyclic tetrapeptides in Penicillium chrysogenum. PLoS ONE. 2014;9:e98212.View ArticlePubMedPubMed CentralGoogle Scholar
- Ali H, Ries MI, Nijland JG, Lankhorst PP, Hankemeier T, Bovenberg RAL, et al. A branched biosynthetic pathway is involved in production of roquefortine and related compounds in Penicillium chrysogenum. PLoS ONE. 2013;8:1–12.View ArticleGoogle Scholar
- Ries MI, Ali H, Lankhorst PP, Hankemeier T, Bovenberg RAL, Driessen AJM, et al. Novel key metabolites reveal further branching of the roquefortine/meleagrin biosynthetic pathway. J Biol Chem. 2013;288:37289–95.View ArticlePubMedPubMed CentralGoogle Scholar
- García-Estrada C, Ullán RV, Albillos SM, Fernández-Bodega MÁ, Durek P, Von Döhren H, et al. A single cluster of coregulated genes encodes the biosynthesis of the mycotoxins roquefortine C and meleagrin in Penicillium chrysogenum. Chem Biol. 2011;18:1499–512.View ArticlePubMedGoogle Scholar
- Pohl C, Kiel JAKW, Driessen AJM, Bovenberg RAL, Nygård Y. CRISPR/Cas9 based genome editing of Penicillium chrysogenum. ACS Synth Biol. 2016;5:754–64.View ArticlePubMedGoogle Scholar
- Nødvig CS, Nielsen JB, Kogle ME, Mortensen UH. A CRISPR-Cas9 system for genetic engineering of filamentous fungi. PLoS ONE. 2015;10:e0133085.View ArticlePubMedPubMed CentralGoogle Scholar